Core Members

Dr. Monika Krzyzanowska
Clinical Director and Founder
Bio and publications
Melanie Powis
Research Director
Bio and publications
Dr. Robert Grant
Medical Oncologist
Bio and publications
Dr. Jean-Pierre Bissonnette
Physicist
Bio and publications
Dr. Genevieve Bouchard-Fortier
Gynecological Oncologist
Bio and publications
Celina Dara
Pharmacy Site Lead
Bio and publications
Dr. Osvaldo Espin-Garcia
Biostatistician
Bio and publications
Victoria Glinsky
Quality Coordinator
Saidah Hack
Clinical Research Coordinator
Bio and publications
Anet Julius
Director of Professional Practice
Bio and publications
Dr. Vishal Kukreti
Malignant Hematologist
Bio and publications
Alyssa Macedo
CQIN Manager
Bio and publications
Dr. Ernie Mak
Palliative Care Physician
Bio and publications
Dr. Janet Papadakos
Co-Director Health Literacy Research Centre
Bio and publications
Lyndon Morley
Radiation Therapist
Bio and publications
Dr. Auro Viswabandya
Malignant Hematologist
Bio and publications
Lisa Tinker
Clinical Director
Bio and publications

Alumni

Dr. Tracy Murphy
Staff Specialist in Leukemia
Bio and publications
Dr. Rebecca Prince
Medical Oncologist
Bio and publications
Sonieya Nagarajah
Internal Medicine Resident
Nazek Abdelmutii
Cancer Strategy and Innovation
Bio and publications
Christopher McChesney
MSc/Undergraduate Medicine
Dr. Lesley Moody
Clinical Director
Bio and publications
Jackelyn Salmini
Graduate Research Student
Lucy Ma
Medical Oncology Fellow
Sanaz Ghazi
Process Improvement Lead

Trainees

Kyle Juliao
BASc. Industrial Engineering, MEng. Candidate
Huaqi Li
Undergraduate Medicine
Erick Saldanha
Medical Oncology Fellow

Summer 2021

Kevin Chen_Headshot (1)
Kevin Chen
Undergraduate Medicine
Zuhal_Mohmand
Zuhal Mohmand
Undergraduate Medicine
placeholder-500x500
Peter Nakhla
Undergraduate Medicine
Abed Baiad
Undergraduate Medicine

Dr. Monika Krzyzanowska MD MPH FRCSC

Dr. Monika Krzyzanowska is a medical oncologist and health services researcher. She obtained her medical degree the University of Toronto and her Master of Public Health in quantitative methods from Harvard University. Dr. Krzyzanowska serves as the Director of the CQuaL lab, an Academic Physician at Princess Margaret Cancer Centre, a Professor of Medicine at the University of Toronto, and the Clinical Lead, Quality Care and Access, Systemic Treatment Program at Cancer Care Ontario. Dr. Krzyzanowska‘s research seeks to understand and improve the quality of cancer care in routine settings.

Publications:

  1. Howell D, Powis M, Kirkby R, Amernic H, Moody L, Bryant-Lukosius D, O’Brien MA, Rask S, Krzyzanowska MK. Improving the quality of self-management support in ambulatory cancer care: a mixed-method study of organisational and clinician readiness, barriers and enablers for tailoring of implementation strategies to multisites. BMJ Qual Saf. 2021 Mar 16;bmjqs-2020-012051.
  2. Berlin A, Lovas M, Truong T, Melwani S, Liu J, Liu ZA, Badzynski A, Carpenter MB, Virtanen C, Morley L, Bhattacharyya O, Escaf M, Moody L, Goldfarb A, Brzozowski L, Cafazzo J, Chua MLK, Stewart AK, Krzyzanowska MK. Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19. JAMA Oncol. 2021 Jan 7:e206982.
  3. Enright KA, Taback N, Powis ML, Gonzalez A, Yun L, Sutradhar R, Trudeau ME, Booth CM, Krzyzanowska MK. Setting Quality Improvement Priorities for Women Receiving Systemic Therapy for Early-Stage Breast Cancer by Using Population-Level Administrative Data. J Clin Oncol. 2017 Oct 1;35(28):3207-3214.

Melanie Powis MSc RAQC PhD Student

Melanie Powis is a toxicologist and health services researcher.  She completed her Master of Science in Pharmacology (specialization: molecular toxicology) from the University of Toronto.  She is currently completing her PhD in Health Services Research- Outcomes and Evaluation in the Institute for Health Policy, Management and Evaluation at the University of Toronto.  Her research focuses on designing and evaluating interventions to address the high rates of acute care utilization due to treatment-related toxicities in the cancer patient population.

Publications:

  1. Howell D, Powis M, Kirkby R, Amernic H, Moody L, Bryant-Lukosius D, O’Brien MA, Rask S, Krzyzanowska M. Improving the quality of self-management support in ambulatory cancer care: a mixed-method study of organisational and clinician readiness, barriers and enablers for tailoring of implementation strategies to multisites. BMJ Qual Saf. 2021 Mar 16:bmjqs-2020-012051.
  2. Phillips C, Deal K, Powis M, Singh S, Dharmakulaseelan L, Naik H, Dobriyal A, Alavi N, Krzyzanowska MK. Evaluating Patients’ Perception of the Risk of Acute Care Visits During Systemic Therapy for Cancer. JCO Oncol Pract. 2020 Jul;16(7):e622-e629.
  3. Powis M, Sutradhar R, Gonzalez A, Enright KA, Taback NA, Booth CM, Trudeau M, Krzyzanowska MK. Establishing achievable benchmarks for quality improvement in systemic therapy for early-stage breast cancer. Cancer. 2017 Oct 1;123(19):3772-3780.

Dr. Robert Grant PhD MD

Robert Grant is a Medical Oncologist and Clinician Investigator at the Princess Margaret Cancer Centre and an Assistant Professor of Medicine at the University of Toronto. He completed his MD and PhD at the University of Toronto. His research applies machine learning to improve outcomes for people with cancer.

Publications:

Grant RC, Moineddin R, Yao Z, Powis M, Kukreti V, Krzyzanowska MK. Development and Validation of a Score to Predict Acute Care Use After Initiation of Systemic Therapy for Cancer. JAMA Netw Open. 2019 Oct 2;2(10):e1912823.

Nadler M, Rose AAN, Prince R, Eng L, Lott A, Grant RC, Jones JM, Enright K. Increasing Referrals of Patients with Gastrointestinal Cancer to a Cancer Rehabilitation Program: A Quality Improvement Initiative. JCO Oncology Practice.2021;17(4):e593-e602

Duan K, Jang GH, Grant RC, Wilson JM, Notta F, O’Kane G, Knox JJ, Gallinger S, Fischer S. The value of GATA6 Immunohistochemistry and Computer-Assisted Diagnosis to Predict Clinical Outcome in Advanced Pancreatic Cancer. Scientific Reports. 2021;11(1):14951.

Dr. Jean-Pierre Bissonnette PhD MCCPM FCOMP

Dr. Jean-Pierre Bissonnette is the Associate Head for Professional and Academic Affairs for the Department of Medical Physics at the Princess Margaret Cancer Centre, where he has been employed since 2003. Prior, he was the coordinator then interim Head of Physics at the Centre Hospitalier de l’Université de Montréal. He graduated from McGill University with a M.Sc., then obtained his Ph.D. from the University of Western Ontario in 1996.  Dr. Bissonnette has been active in several areas relevant to radiotherapy, including quality assurance and patient safety, high-precision radiotherapy for the brain and the lung, post-graduate education, and monitoring response of locally-advanced lung cancer to combined chemo-radiotherapy using CT, CBCT and PET images. Current research topics include dose reconstruction based on image-guidance images, image-based adaptation of therapy and exploring the use of statistical tools to rationalize and limit the cost of quality control work.

Publications:

  1. Bissonnette JP, Neath C, Hart M. Introducing operator characteristic curves to define appropriate frequency of quality control tests: A case study involving whole breast radiotherapy image guidance. Phys Med. 2020 Jan;69:275-280.
  2. Nielsen MK, Malkoske KE, Brown E, Diamond K, Frenière N, Grant J, Pomerleau-Dalcourt N, Schella J, Schreiner LJ, Tantôt L, Villareal-Barajas JE, Bissonnette JP. Production, review, and impact of technical quality control guidelines in a national context. J Appl Clin Med Phys. 2016 Nov 8;17(6):3-15.
  3. Bissonnette JP, Milosevic M, Carlone M, Malkoske KE. Canadian Partnership for Quality Radiotherapy (CPQR) and the Canadian Organization of Medical Physicists (COMP) – Driving safety and quality assurance practice in Canada through the development of technical quality control guidelines. J Appl Clin Med Phys. 2016 Sep 8;17(5):548-549.

Dr. Genevieve Bouchard-Fortier MD FRCSC MSc

Dr. Genevieve Bouchard-Fortier is a graduate of McGill University. She completed a residency program in the Department of Obstetrics and Gynaecology at the University of Toronto. During this time, Dr. Bouchard-Fortier also obtained a Master of clinical epidemiology focusing on cancer screening and cancer prevention at the Harvard School of Public Health. She completed her fellowship in Gynecologic Oncology at the University of Toronto. During that time, she worked on the outcomes of minimally invasive surgeries for gynecologic oncology patients. More recently, she completed a certificate in patient safety and quality improvement with the Center for Quality Improvement and Patient Safety (CQUIPS). Dr. Bouchard-Fortier research and clinical interests include management of gestational trophoblastic disease as well as development of quality metrics to improve gynecologic oncology care.

Publications:

  1. Liu S, Kasherman L, Fazelzad R, Wang L, Bouchard-Fortier G, Lheureux S, Krzyzanowska MK. The use of bevacizumab in the modern era of targeted therapy for ovarian cancer: A systematic review and meta-analysis. Gynecol Oncol. 2021 Feb 2:S0090-8258(21)00088-3.
  2. Nguyen JMV, Ferguson SE, Bernardini MQ, May T, Laframboise S, Hogen L, Bouchard-Fortier G. Preoperative neutrophil-to-lymphocyte ratio predicts 30 day postoperative morbidity and survival after primary surgery for ovarian cancer. Int J Gynecol Cancer. 2020 Sep;30(9):1378-1383.
  3. Bouchard-Fortier G, Ghorani E, Short D, Aguiar X, Harvey R, Unsworth N, Kaur B, Sarwar N, Seckl MJ. Following chemotherapy for gestational trophoblastic neoplasia, do residual lung lesions increase the risk of relapse? Gynecol Oncol. 2020 Sep;158(3):698-701.

Celina Dara

Bio coming soon

Publications:

  1. Bacopoulos AJ, Ho L, Yang A, Ng P, Dara C, Loach D, Deotare U, Michelis FV, Viswabandya A, Kim DD, Lipton JH, Messner HA, Thyagu S. Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit. J Oncol Pharm Pract. 2021 Jan;27(1):33-39.
  2. Ng P, Incekol D, Lee R, Paisley E, Dara C, Brandle I, Kaufman M, Chen C, Trudel S, Tiedemann R, Reece D, Kukreti V. Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3 mL per injection site. J Oncol Pharm Pract. 2015 Aug;21(4):285-92.

Dr. Osvaldo Espin-Garcia PhD

Bio coming soon

Publications:

  1. Ma LX, Taylor K, Espin-Garcia O, Anconina R, Suzuki C, Allen MJ, Honorio M, Bach Y, Allison F, Chen EX, Brar S, Swallow CJ, Yeung J, Darling GE, Wong R, Kalimuthu SN, Jang RW, Veit-Haibach P, Elimova E. Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma. Cancer Med. 2021 Jan;10(1):199-207.
  2. Jiang DM, Sim HW, Espin-Garcia O, Chan BA, Natori A, Lim CH, Moignard S, Chen EX, Liu G, Darling G, Swallow CJ, Brar S, Brierley J, Ringash J, Wong R, Kim J, Rogalla P, Hafezi-Bakhtiari S, Knox JJ, Jang RW, Elimova E. Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer. Oncology. 2021;99(1):49-56.
  3. Darling GE, Sulman J, Espin-Garcia O, Trudel JG, Atenafu EG, Kidane B. Does it matter how we evaluate HRQOL? Longitudinal comparison of the EORTC QLQ-C30/QLQ-OG25 and FACT-E. J Cancer Surviv. 2020 Oct 26.

Saidah Hack BSc

Bio coming soon

Publications:

  1. Vijayan, P., Hack, S., Yao, T., Qureshi, M. A., Paterson, A. D., John, R., Davenport, B., Lennon, R., Pei, Y., & Barua, M. (2021). LAMA2 and LOXL4 are candidate FSGS genes. BMC nephrology, 22(1), 320.
  2. Barua M, John R, Stella L, Li W, Roslin NM, Sharif B, Hack S, Lajoie-Starkell G, Schwaderer AL, Becknell B, Wuttke M, Köttgen A, Cattran D, Paterson AD, Pei Y. X-Linked Glomerulopathy Due to COL4A5 Founder Variant. Am J Kidney Dis. 2018 Mar;71(3):441-445.
  3. Yao T, Udwan K, John R, Rana A, Haghighi A, Xu L, Hack S, Reich HN, Hladunewich MA, Cattran DC, Paterson AD, Pei Y, Barua M. Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. Clin J Am Soc Nephrol. 2019 Feb 7;14(2):213-223.

Anet Julius MN

Anet Julius completed her Master of Nursing at the University of Toronto in 2011, and has been an Advanced Practice Nurse Educator at the Princess Margaret for the inpatient medical radiation, palliative care, and short stay units since 2012. She tool on the role of interim Senior Professional Practice Leader at the Princess Margaret in 2017 and is currently the Interim Director of Professional Practice. Anet has been involved in various initiatives to improve patient care and nursing practice at UHN. She holds an Adjunct Lecturer appointment with the Lawrence S. Bloomberg Faculty of Nursing, University of Toronto. Anet has also been a frequent lecturer for UHN-Princess Margaret’s International program teaching the Specialized Oncology Nursing Curriculum in Kuwait and Qatar.

Publications:

  1. Martina K, Ghadimi L, Julius A, Incekol D, Savage P. Redesigning and implementing a Canadian oncology nursing curriculum for an international partnership. Can Oncol Nurs J. 2019 Oct 1;29(4):242-246.

Dr. Vishal Kukreti MD FRCPC

Bio coming soon

Publications:

  1. Pardhan A, Vu K, Gallo-Hershberg D, Forbes L, Gavura S, Kukreti V. Evolving Best Practice for Take-Home Cancer Drugs. JCO Oncol Pract. 2020 Oct 20:OP2000448. doi: 10.1200/OP.20.00448.
  2. Moradian S, Krzyzanowska M, Maguire R, Kukreti V, Amir E, Morita PP, Liu G, Howell D. Feasibility randomised controlled trial of remote symptom chemotherapy toxicity monitoring using the Canadian adapted Advanced Symptom Management System (ASyMS-Can): a study protocol. BMJ Open. 2020 Jun 17;10(6):e035648.
  3. Grant RC, Moineddin R, Yao Z, Powis M, Kukreti V, Krzyzanowska MK. Development and Validation of a Score to Predict Acute Care Use After Initiation of Systemic Therapy for Cancer. JAMA Netw Open. 2019 Oct 2;2(10):e1912823.

Alyssa Macedo MSc OT

Alyssa is the Quality Project Manager for the Department of Medical Oncology and Hematology and Princess Margaret Cancer Centre. She has a Master of Science in Occupational Therapy (OT) from Brunel University in the UK, a Bachelor of Science in OT from the University of Toronto as well as a Bachelor of Science, Honors Biochemistry from McMaster University. Alyssa has practiced as an OT at the University Health Network (UHN) and in the UK.

Publications:

  1. Elliott M, Macedo A, Escaf M. Building Resilience within Institutions Together with Employees (BRITE): Preliminary experience with implementation in an academic cancer centre. Healthc Manage Forum. 2021 Mar;34(2):107-114.
  2. Li M, Sanders C, Lee CH, Gascon B, Macedo A, Molloy S, Laframboise S, Leung YW. Symptom screening for constipation in oncology: getting to the bottom of the matter. Support Care Cancer. 2019 Jul;27(7):2463-2470.
  3. Li M, Macedo A, Crawford S, Bagha S, Leung YW, Zimmermann C, Fitzgerald B, Wyatt M, Stuart-McEwan T, Rodin G. Easier Said Than Done: Keys to Successful Implementation of the Distress Assessment and Response Tool (DART) Program. J Oncol Pract. 2016 May;12(5):e513-26.

Dr. Ernie Mak MD

Bio coming soon

Publications:

  1. Hannon B, Mak E, Al Awamer A, Banerjee S, Blake C, Kaya E, Lau J, Lewin W, O’Connor B, Saltman A, Zimmermann C. Palliative care provision at a tertiary cancer center during a global pandemic. Support Care Cancer. 2021 May;29(5):2501-2507.
  2. Zimmermann C, Ryan S, Hannon B, Saltman A, Rodin G, Mak E, Al-Awamer A, Lau J. Team-based outpatient early palliative care: a complex cancer intervention. BMJ Support Palliat Care. 2019 Aug 12:bmjspcare-2019-001903.
  3. Hannon B, Swami N, Pope A, Rodin G, Dougherty E, Mak E, Banerjee S, Bryson J, Ridley J, Zimmermann C. The oncology palliative care clinic at the Princess Margaret Cancer Centre: an early intervention model for patients with advanced cancer. Support Care Cancer. 2015 Apr;23(4):1073-80.

Dr. Janet Papadakos MEd PhD

Over the last fifteen years Janet’s research and professional program has centred on three main platforms: 1. Health Literacy: Developing interventions to mitigate impact of low health literacy, 2. Self-management: Engaging patient and families to participate in their care and 3. Patient education: Advancing patient and family health knowledge.  More recently Janet’s research interests have expanded to include health professional education, continuing professional development and health professional communication competency.

Publications:

  1. Giuliani M, Samoil D, Agarwal A, Croke J, Golden DW, Hirsch AE, Jimenez R, Malik NH, Papadakos J, Wu CHD, Ingledew PA. Exploring the perceived educational impact of COVID-19 on postgraduate training in oncology: impact of self-determination and resilience. Can Med Educ J. 2021 Feb 26;12(1):e180-e181.
  2. Giannopoulos E, Papadakos J, Cameron E, Brual J, Truscott R, Evans WK, Giuliani ME. Identifying Best Implementation Practices for Smoking Cessation in Complex Cancer Settings. Curr Oncol. 2021 Jan 13;28(1):471-484.
  3. Liederman Z, Quartey NK, Ward R, Papadakos J. Exploration of Barriers and Facilitators to Optimal Emergency Department Care of Sickle Cell Disease: Opportunities for Patient-Physician Partnerships to Improve Care. Hemoglobin. 2020 Dec 17:1-12.

Lyndon Morley MRT(T)

Lyndon Morley is the practice leader, quality and safety in the radiation medicine program. He is a graduate of the Medical Radiation Sciences BSc/Diploma program offered jointly by the University of Toronto Department of Radiation Oncology and the Michener Institute. Additionally, he holds a Project Management Professional certification from the Project Management Institute and is working on a Quality Engineer certificate. He is interested in improving the quality of radiation medicine through process improvement and quality data science.

Publications:

  1. Berlin A, Lovas M, Truong T, Melwani S, Liu J, Liu ZA, Badzynski A, Carpenter MB, Virtanen C, Morley L, Bhattacharyya O, Escaf M, Moody L, Goldfarb A, Brzozowski L, Cafazzo J, Chua MLK, Stewart AK, Krzyzanowska MK. Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19. JAMA Oncol. 2021 Jan 7:e206982.
  2. Loudon J, Morley L. Balancing Projects and Operations to Improve Organizational Capability. J Med Imaging Radiat Sci. 2019 Jun;50(2):199-205.
  3. Felder S, Morley L, Ng E, Chan K, Ballantyne H, Di Tomasso A, Borg J, Bissonnette JP, Breen S, Waldron J, Rink A, Milosevic M. Brachytherapy patient safety events in an academic radiation medicine program. Brachytherapy. 2018 Jan-Feb;17(1):16-23.

Dr. Auro Viswabandya MD DM FRCP FRCPC

Bio coming soon

Publications:

  1. Law AD, Bhella S, Pasic I, Lam W, Michelis FV, Gerbitz A, Viswabandya A, Kumar R, Lipton JH, Mattsson J, Kim DDH. Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation. Ann Hematol. 2021 Mar 12.
  2. Pasic I, Alanazi W, Dranitsaris G, Lieberman L, Viswabandya A, Kim DDH, Lipton JH, Michelis FV. Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients: A prospective study of feasibility, safety, and healthcare resource use. Hematol Oncol Stem Cell Ther. 2021 Feb 23:S1658-3876(21)00001-7.
  3. Al-Shaibani E, Cyriac S, Chen S, Lipton JH, Kim DD, Viswabandya A, Kumar R, Lam W, Law A, Al-Shaibani Z, Gerbitz A, Pasic I, Mattsson J, Michelis FV. Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia. Clin Lymphoma Myeloma Leuk. 2021 Feb 3:S2152-2650(21)00039-2.

Lisa Tinker

Bio coming soon

Publications:

  1. Samoil D, Abdelmutti N, Gallagher LO, Jivraj N, Quartey NK, Tinker L, Giuliani M, Trang A, Ferguson SE, Papadakos J. Evaluating the effect of a group pre-treatment chemotherapy psycho-education session for chemotherapy-naive gynecologic cancer patients and their caregivers. Gynecol Oncol. 2021 Jan;160(1):234-243.
  2. Lee YC, Jivraj N, Wang L, Chawla T, Lau J, Croke J, Allard JP, Stuart-McEwan T, Nathwani K, Bowering V, Karakasis K, O’Brien C, Shlomovitz E, Ferguson SE, Buchanan S, Ng P, Cyriac S, Tinker L, Dhani N, Oza AM, Lheureux S. Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer. J Oncol Pract. 2019 Dec;15(12):e1066-e1075.
  3. Drummond N, Jolicoeur L, Brodeur J, Dalbello D, Giroux J, Jones T, Marceau H, Power J, Thomas H, Tinker L. Communities of practice: working in new ways to advance gynecologic oncology nursing. Can Oncol Nurs J. 2010 Fall;20(4):204-5.

Dr. Tracy Murphy- Staff Specialist in Leukemia

Dr. Murphy graduated with an honours degree in medicine from University College Cork in Ireland in 2004 and obtained her membership of the Royal College of Physicians in 2009. She moved to Cambridge University Hospital for further hematology training and was based in Addenbrookes hospital for 3 years and in associated district general hospitals. She spent a year in Sydney, Australia with a focus on pathology training. She obtained her FRCPath in 2014 and completed her training in 2015.

Publications:

  1. Daher-Reyes G, Kim T, Novitzky-Basso I, Kim KH, Smith A, Stockley T, Capochichi JM, Al-Shaibani Z, Pasic I, Law A, Lam W, Michelis FV, Gerbitz A, Viswabandya A, Lipton J, Kumar R, Mattsson J, Schimmer A, McNamara C, Murphy T, Maze D, Gupta V, Sibai H, Chan S, Yee K, Minden M, Zhang Z, Schuh A, Kim DDH. Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplant. 2021 Mar 25.
  2. Nadler MB, Barry A, Murphy T, Prince R, Elliott M. Strategies to support health care providers during the COVID-19 pandemic. CMAJ. 2020 May 11;192(19):E522.
  3. Barry A, Murphy T, Prince R, May T, Zimmermann C, Elliott M. Time to “Buddy Up”-Simple Strategies to Support Oncologists During the Coronavirus Disease 2019 Pandemic. Adv Radiat Oncol. 2020 Apr 20;5(4):601-602.

Dr. Rebecca Prince MBBS

Bio coming soon

Publications:

  1. Nadler MB, Rose AAN, Prince R, Eng L, Lott A, Grant RC, Jones JM, Enright K. Increasing Referrals of Patients With Gastrointestinal Cancer to a Cancer Rehabilitation Program: A Quality Improvement Initiative. JCO Oncol Pract. 2020 Dec 8:OP2000432.
  2. Prince RM, Soung Yee A, Parente L, Enright KA, Grunfeld E, Powis M, Husain A, Gandhi S, Krzyzanowska MK. User-Centered Design of a Web-Based Tool to Support Management of Chemotherapy-Related Toxicities in Cancer Patients. J Med Internet Res. 2019 Mar 28;21(3):e9958.
  3. Prince RM, Powis M, Zer A, Atenafu EG, Krzyzanowska MK. Hospitalisations and emergency department visits in cancer patients receiving systemic therapy: Systematic review and meta-analysis. Eur J Cancer Care (Engl). 2019 Jan;28(1):e12909.

Nazek Abdelmutti

Nazek Abdelmutti is the manager of cancer strategy and stewardship at Princess Margaret Cancer Centre. She holds a Masters in Health Promotion from the University of Waterloo.  Her professional interests include health literacy, health communication and e-tools.

Publications:

  1. Samoil D, Abdelmutti N, Gallagher LO, Jivraj N, Quartey NK, Tinker L, Giuliani M, Trang A, Ferguson SE, Papadakos J. Evaluating the effect of a group pre-treatment chemotherapy psycho-education session for chemotherapy-naive gynecologic cancer patients and their caregivers. Gynecol Oncol. 2021 Jan;160(1):234-243.
  2. Brual J, Abdelmutti N, Agarwal A, Arisz A, Benea A, Lord B, Massey C, Giuliani M, Stuart-McEwan T, Papadakos J. Developing an Education Pathway for Breast Cancer Patients Receiving Rapid Diagnostic Testing: Investigating Informational and Supportive Care Needs. J Cancer Educ. 2020 Jul 31.
  3. Jivraj N, Gallagher LO, Papadakos J, Abdelmutti N, Trang A, Ferguson SE. Empowering patients and caregivers with knowledge: The development of a nurse-led gynecologic oncology chemotherapy education class. Can Oncol Nurs J. 2018 Feb 1;28(1):4-7.

Dr. Lesley Moody PhD

Bio coming soon

Publications:

  1. Gagliardi AR, Martinez JPD, Baker GR, Moody L, Scane K, Urquhart R, Wodchis WP. Hospital capacity for patient engagement in planning and improving health services: a cross-sectional survey. BMC Health Serv Res. 2021 Feb 25;21(1):179.
  2. Berlin A, Lovas M, Truong T, Melwani S, Liu J, Liu ZA, Badzynski A, Carpenter MB, Virtanen C, Morley L, Bhattacharyya O, Escaf M, Moody L, Goldfarb A, Brzozowski L, Cafazzo J, Chua MLK, Stewart AK, Krzyzanowska MK. Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19. JAMA Oncol. 2021 Jan 7:e206982.
  3. Campbell C, Nowell A, Karagheusian K, Giroux J, Kiteley C, Martelli L, McQuestion M, Quinn M, Rowe Samadhin YP, Touw M, Moody L. Practical innovation: Advanced practice nurses in cancer care. Can Oncol Nurs J. 2020 Jan 1;30(1):9-15.